Multifaceted toxicity assessment of catalyst composites in transgenic zebrafish embryos

The Green toxicology approach: Insight towards the eco-toxicologically safe development of benign catalysts

Green toxicology is a novel approach increasingly applied for the development of materials and chemicals that are more benign to the environment and human health than their conventional counterparts. It includes predictive eco-toxicological assessments of chemicals during the early developmental process to exclude adverse effects. In the present study, two guanidine zinc catalysts for the ring-opening polymerization of lactide were investigated using eco-toxicological tools. Namely, the fish embryo toxicity assay for teratogenic effects, the ER (α) CALUX assay for endocrine activity and the Ames fluctuation assay for mutagenic potential were applied. Both complexes showed no endocrine activity, mutagenicity or acute aquatic toxicity, however a delayed hatch could be observed, therefore suggesting potential effects on a molecular level. This proof-of-concept study aims to assess the toxicity of guanidine zinc catalysts and is a first step towards the incorporation of toxicological assessments into chemical developmental processes to achieve a sustainable and safe production of catalysts.

Toxicity evaluation of bulk and nanosheet MoS2 catalysts using battery bioassays

Herein, the main aim is to study the influence of the materials' structural properties on their ecotoxicological properties. The acute toxicity of the bulk (molybdenum disulfide) MoS₂ and 2D nanosheet MoS₂ was investigated using organisms of four different taxonomic groups. Ultrasound-assisted liquid-phase exfoliation method was used for preparing 2D nanosheets from bulk MoS₂. Bulk and nanosheet MoS₂ were characterized using scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FT-IR), and X-ray diffraction (XRD) analyses. The acute toxicity of the bulk and nanosheet MoS₂ catalysts was evaluated with four different bioassays using the test organisms Vibrio fischeri (a marine photobacterium), Pseudokirchnerialla subcapitata (a freshwater microalga), Daphnia magna (a freshwater crustacean) and the freshwater duckweed Spirodela polyrhiza. The toxic effect of the materials depended on their structural/size features and the type/sensitivity of the test organism. Generally speaking, bulk MoS₂ was more toxic than its nanosheet form. The freshwater crustacean Daphnia magna appeared to be the most suitable, easy-to-handle, and at the same time sensitive test organism for bulk and nanosheet MoS₂ among the tested organisms.

Zebrafish (Danio rerio) as an excellent vertebrate model for the development, reproductive, cardiovascular, and neural and ocular development toxicity study of hazardous chemicals

In the past decades, the type of chemicals has gradually increased all over the world, and many of these chemicals may have a potentially toxic effect on human health. The zebrafish, as an excellent vertebrate model, is increasingly used for assessing chemical toxicity and safety. This review summarizes the efficacy of zebrafish as a model for the study of developmental toxicity, reproductive toxicity, cardiovascular toxicity, neurodevelopmental toxicity, and ocular developmental toxicity of hazardous chemicals, and the transgenic zebrafish as biosensors are used to detect the environmental pollutants.

The Potential of Zebrafish as a Model Organism for Improving the Translation of Genetic Anticancer Nanomedicines

In the last few decades, the field of nanomedicine applied to cancer has revolutionized cancer treatment: several nanoformulations have already reached the market and are routinely being used in the clinical practice. In the case of genetic nanomedicines, i.e., designed to deliver gene therapies to cancer cells for therapeutic purposes, advances have been less impressive. This is because of the many barriers that limit the access of the therapeutic nucleic acids to their target site, and the lack of models that would allow for an improvement in the understanding of how nanocarriers can be tailored to overcome them. Zebrafish has important advantages as a model species for the study of anticancer therapies, and have a lot to offer regarding the rational development of efficient delivery of genetic nanomedicines, and hence increasing the chances of their successful translation. This review aims to provide an overview of the recent advances in the development of genetic anticancer nanomedicines, and of the zebrafish models that stand as promising tools to shed light on their mechanisms of action and overall potential in oncology.

Zebrafish models for functional and toxicological screening of nanoscale drug delivery systems: promoting preclinical applications

Preclinical screening with animal models is an important initial step in clinical translation of new drug delivery systems. However, establishing efficacy, biodistribution, and biotoxicity of complex, multicomponent systems in small animal models can be expensive and time-consuming. Zebrafish models represent an alternative for preclinical studies for nanoscale drug delivery systems. These models allow easy optical imaging, large sample size, and organ-specific studies, and hence an increasing number of preclinical studies are employing zebrafish models. In this review, we introduce various models and discuss recent studies of nanoscale drug delivery systems in zebrafish models. Also in the end, we proposed a guideline for the preclinical trials to accelerate the progress in this field.